Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New test detects Johne’s disease in day-old calves
The trial proves that early detection of live MAP infection is possible.
Researchers assess effectiveness of new Actiphage system 

Researchers have developed a new diagnostic system that can reliably detect Johne’s disease in the blood of day-old calves.  

The Actiphage system, unveiled at the European Association of Veterinary Laboratory Diagnosticians (EAVLD) Congress, can identify live mycobacterial infection in a range of tissue types, including blood and faeces.

Current tests for Johne’s disease only allow the reliable detection of Mycobacterium avium subsp. paratuberculosis (MAP) in 18-24 month calves and are unable to distinguish between active and passive infection.

In a 16-month trial, researchers tested PBD Biotech’s Actiphage Rapid Kit and Biosellal’s Bio-T Kit on calves from three different herds. The calves were born from MAP-positive and MAP negative calves, and the tests were carried out on both blood and faeces samples.

Researchers found that the Actiphage system could identify live MAP infection at least four weeks earlier than the faecal PCR in 75 per cent of cases. In one case, the new diagnostic detected MAP in the blood of a one-day-old calf born from a MAP-positive cow.

Researchers say the trial proves that early detection of live MAP infection is possible, and paves the way for improved Johne’s disease monitoring and control measures on farms.

Co-Author Dr Ben Swift, R&D Director at PBD Biotech, explains, “Young animals are highly susceptible to infection and being able to identify Johne’s disease at this early stage is key to controlling disease spread.

"The trial showed that the sensitivity and specificity of Actiphage enables detection of lower levels of MAP than the current culture methods, and provides results in six hours rather than weeks.”

Claire Pelletier, Directrice Générale of BioDev, consultant to Biosellal, adds: “The study showed that two calves, identified as MAP-positive by Actiphage-PCR on blood during the first monthly sampling didn’t shed MAP into their faeces until 10 and 11 months. This emphasises that early detection provides a short window of time that allow for control of the disease.”

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.